Detalles de la búsqueda
1.
Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status.
BMC Med
; 20(1): 142, 2022 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484593
2.
Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo.
Cell Commun Signal
; 20(1): 142, 2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104708
3.
Submuscular Implant-Based Breast Reconstruction Using a Musculofascial Pocket Formed by the Pectoralis Major Muscle and the Serratus Anterior Muscle Fascia: A Novel Surgical Approach.
World J Surg
; 46(6): 1451-1456, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355101
4.
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
Breast Cancer Res Treat
; 183(2): 321-332, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638235
5.
Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer.
Chin J Cancer Res
; 30(3): 340-350, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30046228
6.
Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Cancer Med
; 12(5): 5195-5208, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404592
7.
Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.
Breast Cancer
; 30(1): 77-87, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129636
8.
YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer.
Cancer Biomark
; 35(2): 127-142, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342079
9.
Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer.
DNA Cell Biol
; 41(5): 521-538, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35475703
10.
Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature.
Clin Med Insights Oncol
; 16: 11795549211072880, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237089
11.
Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis.
Oncol Lett
; 23(2): 68, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069877
12.
Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.
Front Oncol
; 12: 830124, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402236
13.
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing.
Breast Cancer
; 28(3): 644-652, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386585
14.
Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics.
J Cancer
; 12(14): 4408-4417, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093841
15.
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.
Front Oncol
; 11: 618767, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33968723
16.
Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients.
Cancer Manag Res
; 13: 3055-3065, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854375
17.
Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
EBioMedicine
; 71: 103542, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454403
18.
Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer.
Onco Targets Ther
; 13: 615-621, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32021303
19.
The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Gene
; 759: 144970, 2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711101
20.
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA.
Thorac Cancer
; 11(7): 1861-1868, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412177